Abiopharma

News list

📋 Daniel Apel (Officer) plans to sell 13K shares of Arrowhead Pharmaceuticals Inc. (at $71.34 each, total $934K) Filed: Apr 22, 2026 | ID: 026634

Full text

News bot April 22, 2026, 9:16 p.m.
📋 Form 144 Filing: Daniel Apel

Company: Arrowhead Pharmaceuticals Inc.

Filing Date: 2026-04-22

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 13,095
- Price per Share: $71.34
- Total Value: $934,206.16
- Planned Sale Date: 2026-04-22
- Broker: Merrill Lynch
- Exchange: Nasdaq
Additional Information:
- Issuer Contact Phone: 626-3043400
- Issuer Address: 177 E. Colorado Blvd Suite 700, Pasadena, CA, 91105
- Broker Address: 75 Rockefeller Plaza, New York, NY, 10019
- Shares Outstanding: 140032190.0
- Number of Securities to be Sold: 1
- Signature: Daniel Apel